Colchicine/Olsalazine sodium

秋水仙碱/奥沙拉秦钠

Report date: 2022/01/14 13:23:58

Base Information

Drug NameColchicine/Olsalazine sodium
Drug Alias NameColchicine and Olsalazine sodium秋水仙碱+奥沙拉秦钠秋水仙碱奥沙拉秦钠Olsalazine sodium/ColchicineOlsalazine and Colchicine +[11] 
ClassificationSmall molecules
Mechanisms of ActionTubulin polymerisation inhibitors
TargetsTubulin
Therapy Area/IndicationsIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes ColchicineOlsalazine sodium
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCentre For Digestive Diseases
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCentre For Digestive DiseasesGiaconda Ltd
Active IndicationsN/A
Inactive IndicationsIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A